Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Early treatment may not cure HIV
rhesus monkey
SIV re-emerged in all of the monkeys when treatment stopped after six months.
New research on rhesus monkeys “sobering”

Early treatment may not be enough to cure HIV according to new research described as “sobering” by scientists.

According to research published online in the journal Nature, the most important barrier to finding a cure for HIV is the viral reservoir, where it can lie dormant for many years, invulnerable to drugs.   

In a study carried out on rhesus monkeys, US researchers found that this viral reservoir was established surprisingly early after intrarectal infection with simian immunodeficiency virus (SIV), and before it became detectable in the blood.

“The viral reservoir was seeded substantially earlier after infection than was previously recognized,” explained Dan Barouch, senior author and professor of medicine at Harvard Medical School.

“We found that the reservoir was established in tissues during the first few days of infection, before the virus was even detected in the blood.”

Groups of monkeys were given antiretroviral therapy (ART) on days three, seven, 10 or 14, after infection with SIV. Animals treated on day three showed no evidence of SIV in the bloodstream and did not display any SIV-specific immune responses.

However, after six months of ART, all monkeys showed viral resurgence after treatment was stopped.

While there was a delay in the amount of time it took for virus replication to be seen in the blood of animals treated after three days compared to those treated on day seven, 10 or 14, scientists say further strategies will be needed to cure HIV.

The findings are a blow to hopes that early treatment may offer a cure for HIV. This follows recent news that HIV has re-emerged in the “Mississippi baby” - who was previously thought to have been cured through early treatment with ART.

“The unfortunate news of the virus rebounding in this child further emphasizes the need to understand the early and refractory viral reservoir that is established very quickly following HIV infection in humans,” said Professor Barouch.

Authors of the research wrote that their findings “present new challenges to HIV-1 eradication efforts.”

“Our data suggest that extremely early initiation of ART, extended ART duration and probably additional interventions that activate the viral reservoir will be required for HIV-1 eradication.”



Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.